Literature DB >> 6088368

Single blind comparative study of ranitidine and cimetidine in patients with gastric ulcer. The Belgian Peptic Ulcer Study Group.

.   

Abstract

In a single blind multicentre study, the efficacy and safety of ranitidine was compared with cimetidine in patients with gastric ulcer confirmed by endoscopy. Patients were randomly allocated to receive either 150 mg ranitidine twice daily, or 200 mg cimetidine three times a day and 400 mg at night for four weeks; patients with unhealed ulcers continued the same treatment for a further two weeks. Out of 260 patients, 197 were analysed. Of the ranitidine treated patients, 66% were healed after four weeks and 78% after six weeks and of the cimetidine treated patients 62% were healed after four weeks and 87% after six weeks. These differences are not significant. These results confirmed that ranitidine is as effective as cimetidine in the acute treatment of gastric ulcer.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088368      PMCID: PMC1432481          DOI: 10.1136/gut.25.9.999

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  9 in total

1.  Investigations on the penetration of ranitidine into the cerebrospinal fluid and a comparison of the effects of ranitidine and cimetidine on male sex hormones.

Authors:  R P Walt; S J LaBrooy; A Avgerinos; T Oehr; A Riley; J J Misiewicz
Journal:  Scand J Gastroenterol Suppl       Date:  1981-06

2.  Comparison of ranitidine and cimetidine in the inhibition of histamine, sham-feeding, and meal-induced gastric secretion in duodenal ulcer patients.

Authors:  S J Konturek; W Obtulowicz; N Kwiecien; E Sito; E Mikos; J Oleksy
Journal:  Gut       Date:  1980-03       Impact factor: 23.059

3.  Gastric inhibitory action of H2-antagonists ranitidine and cimetidine.

Authors:  W Domschke; G Lux; S Domschke
Journal:  Lancet       Date:  1979-02-10       Impact factor: 79.321

4.  Interaction of ranitidine with liver microsomes.

Authors:  S Rendić; T Alebić-Kolbah; F Kajfez; H H Ruf
Journal:  Xenobiotica       Date:  1982-01       Impact factor: 1.908

5.  Cimetidine and placebo in the treatment of benign gastric ulcer: a multicenter double blind study.

Authors:  W P Dyck; A Belsito; B Fleshler; T R Liebermann; P B Dickinson; J M Wood
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

6.  Cimetidine in patients with gastric ulcer: a multicentre controlled trial.

Authors:  F Frost; I Rahbek; S J Rune; K B Jensen; E Gudmand-Hoyer; E Krag; J Rask-Madsen; H R Wulff; J Garbol; K G Jensen; M Hojlund; V R Nissen
Journal:  Br Med J       Date:  1977-09-24

7.  Inhibition of pentagastrin-stimulated and nocturnal gastric secretion by ranitidine. A new H2-receptor antagonist.

Authors:  N R Peden; J H Saunders; K G Wormsley
Journal:  Lancet       Date:  1979-03-31       Impact factor: 79.321

8.  Ranitidine in the treatment of gastric ulceration.

Authors:  J P Wright; I N Marks; A S Mee; A H Girdwood; P C Bornman; N H Gilinsky; P Tobias; W Lucke
Journal:  S Afr Med J       Date:  1982-01-30

9.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

  9 in total
  4 in total

1.  Short-term treatment of gastric ulcer. A meta-analytical evaluation of blind trials.

Authors:  F Di Mario; G Battaglia; G Leandro; G Grasso; F Vianello; S Vigneri
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

2.  Markers of slow-healing peptic ulcer in the elderly. A study on 1,052 ranitidine-treated patients.

Authors:  G Battaglia; F Di Mario; P Dotto; G Leandro; A Pilotto; M Ferrana; F Vianello; S Vigneri; C V Colonna; R Naccarato
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

Review 3.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

4.  Do concomitant diseases and therapies affect the persistence of ulcer symptoms in the elderly?

Authors:  F Di Mario; G Leandro; G Battaglia; A Pilotto; P Del Santo; F Vianello; M Franceschi; M Ferrana; T Dal Bianco; S Vigneri
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.